Ridgewood, NJ, United States of America

Wojtek Auerbach

This inventor holds 35 USPTO granted patents and 13 published patent applications, plus 10 CIPO patents and 19 EPO patents, primarily in Genetic Modification. Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2007-2026.

USPTO Granted Patents = 35 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.5

ph-index = 8

Forward Citations = 542(Granted Patents)


Company Filing History:


Years Active: 2007-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Genetic Modification
Targeted Genome Editing
Pluripotent Cells
Fertile XY Females
Paired Guide RNAs
Nuclease-Mediated Targeting
Mouse ES Cells
Homozygous Modifications
Mouse Genome
Targeted Locus
Conditioned Culture Media
Animal Genetics
35 patents (USPTO):Explore Patents

Title: The Innovative Journey of Wojtek Auerbach

Introduction: Wojtek Auerbach, a talented inventor based in Ridgewood, NJ, has made significant contributions to the field of technology with his creative solutions and groundbreaking ideas.

Latest Patents: Wojtek Auerbach holds several patents in the areas of artificial intelligence, renewable energy, and sustainable design, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for problem-solving, Wojtek Auerbach has successfully brought several cutting-edge products to market, revolutionizing industries and improving the lives of many.

Collaborations: Throughout his career, Wojtek Auerbach has collaborated with leading tech companies, research institutions, and universities to further develop his inventions and bring them to the forefront of innovation.

Conclusion: Wojtek Auerbach's dedication to pushing the boundaries of technology and his commitment to creating a more sustainable future make him a true visionary in the world of inventions and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…